- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股进入多头行情中，股价短线上涨概率较大。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有6家主力机构披露2025-06-30报告期持股数据，持仓量总计1.23亿股，占流通A股17.29%
- 波段诊断：
-
技术面诊股
诊断结果：5.7技术面打败了58%的股票
技术面评分前10的股票
近期的平均成本为5.63元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为5.63元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.63","date":1766477793,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2025.12.24","stock":"1.43","trade":null,"ind":"0.88"},{"date":"2025.12.23","stock":"-1.59","trade":null,"ind":"0.27"},{"date":"2025.12.22","stock":"2.53","trade":null,"ind":"1.47"},{"date":"2025.12.19","stock":"0.73","trade":null,"ind":"0.66"},{"date":"2025.12.18","stock":"0.37","trade":null,"ind":"-1.29"},{"date":"2025.12.17","stock":"-0.18","trade":null,"ind":"2.40"},{"date":"2025.12.16","stock":"-2.14","trade":null,"ind":"-1.51"},{"date":"2025.12.15","stock":"1.82","trade":null,"ind":"-1.10"},{"date":"2025.12.12","stock":"-0.18","trade":null,"ind":"0.84"},{"date":"2025.12.11","stock":"-1.96","trade":null,"ind":"-1.27"},{"date":"2025.12.10","stock":"-0.18","trade":null,"ind":"0.29"},{"date":"2025.12.09","stock":"-0.88","trade":null,"ind":"-0.39"},{"date":"2025.12.08","stock":"0.18","trade":null,"ind":"1.39"},{"date":"2025.12.05","stock":"0.71","trade":null,"ind":"1.08"},{"date":"2025.12.04","stock":"-1.57","trade":null,"ind":"0.40"},{"date":"2025.12.03","stock":"0.88","trade":null,"ind":"-0.78"},{"date":"2025.12.02","stock":"-1.56","trade":null,"ind":"-0.68"},{"date":"2025.12.01","stock":"-0.35","trade":null,"ind":"1.25"},{"date":"2025.11.28","stock":"-0.17","trade":null,"ind":"0.85"},{"date":"2025.11.27","stock":"0.70","trade":null,"ind":"-0.25"},{"date":"2025.11.26","stock":"0.00","trade":null,"ind":"1.02"}]
ST凯利,深证成指,医疗器械指数
压力支撑
该股压力位为5.62元，支撑位为5.54元。
[{"text":"\u538b\u529b\u4f4d","value":"5.62","date":1766505600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.54","date":1766505600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.2资金面打败了39%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体无进出。
更新时间：12月24日 20:30
| 机构今日流向(万元) | 78.94 | 机构5日流向(万元) | -377.43 |
| 机构10日流向(万元) | -1498.53 | 机构20日流向(万元) | -5298.68 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少1127.9万股，其中基金数没有增加，主力净减仓64家，请投资者中长期谨慎为宜。
截止2025-06-30，共6家主力机构（一般法人6家），持仓量总计12312.74万股，占流通A股17.29%
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：3家 ，持有1184.5万股
从主力名单中消失：67家 ，原持有2393.78万股
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：3家 ，持有1184.5万股
从主力名单中消失：67家 ，原持有2393.78万股
消息面诊股
诊断结果：5.1消息面打败了33%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- ST凯利：目前公司出售洁诺医疗股权并减资退出上海景
2025-12-15 - ST凯利：努力做好经营管理，不断提升公司的投资价值
2025-12-04 - ST凯利：目前公司的主营产品里未包含消毒水、消炎药
2025-11-27 - ST凯利前任总经理隐瞒小姨子关系，超4000万关联
2025-11-27 - ST凯利拟将对动之医学持股比例提高至50.9014
2025-11-21 - ST凯利：拟对动之医学增资2000万
2025-11-21 - ST凯利：公司新一届董事会成立以来，始终高度重视研
2025-11-19 - 利润大增623%，骨科市场春天回来了
2025-11-19 - ST凯利：公司2024年度国外市场营业收入为219
2025-11-13 - ST凯利：刘庆女士已报名参加深交所董秘资格培训
2025-11-06
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2025-11-21 |
| 一般消息 | 重大事项 | 关联交易 | 2025-11-21 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-11-04 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-10-28 |
| 一般消息 | 高管变动 | 任职总经理 | 2025-10-21 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-10-13 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-09-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-09-30 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-09-29 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-08-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-08-26 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-26 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-08-06 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-24 |
| 一般消息 | 高管变动 | 委员会调整 | 2025-06-21 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-06-09 |
| 一般消息 | 高管变动 | 个人原因 | 2025-06-06 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-05-16 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-16 |
| 一般消息 | 高管变动 | 解聘 | 2025-05-11 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-10 |
| 利空 | 上市变动 | 特别处理ST | 2025-05-06 |
| 一般消息 | 高管变动 | 委员会调整 | 2025-05-03 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-30 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-04-28 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：3.5行业面打败了55%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2025.12.24","price":"0.88","value":null},{"date":"2025.12.23","price":"0.27","value":null},{"date":"2025.12.22","price":"1.47","value":null},{"date":"2025.12.19","price":"0.66","value":null},{"date":"2025.12.18","price":"-1.29","value":null},{"date":"2025.12.17","price":"2.40","value":null},{"date":"2025.12.16","price":"-1.51","value":null},{"date":"2025.12.15","price":"-1.10","value":null},{"date":"2025.12.12","price":"0.84","value":null},{"date":"2025.12.11","price":"-1.27","value":null},{"date":"2025.12.10","price":"0.29","value":null},{"date":"2025.12.09","price":"-0.39","value":null},{"date":"2025.12.08","price":"1.39","value":null},{"date":"2025.12.05","price":"1.08","value":null},{"date":"2025.12.04","price":"0.40","value":null},{"date":"2025.12.03","price":"-0.78","value":null},{"date":"2025.12.02","price":"-0.68","value":null},{"date":"2025.12.01","price":"1.25","value":null},{"date":"2025.11.28","price":"0.85","value":null},{"date":"2025.11.27","price":"-0.25","value":null},{"date":"2025.11.26","price":"1.02","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 康众医疗 | 42.30% | 4.30% | 6.3分 |
| 2 | 翔宇医疗 | 16.07% | 6.49% | 5.6分 |
| 3 | 福瑞医科 | 13.52% | 5.85% | 6.2分 |
| 4 | 五洲医疗 | 12.26% | -5.50% | 5.2分 |
| 5 | 美好医疗 | 9.08% | 6.87% | 6.4分 |
| 6 | 南微医学 | 8.79% | 2.93% | 5.9分 |
| 8 | 爱朋医疗 | 7.29% | 7.75% | 5.5分 |
| 10 | 奥精医疗 | 7.11% | 8.14% | 5.6分 |
| 12 | 华兰股份 | 6.79% | 2.60% | 5.3分 |
| 14 | 迈普医学 | 5.37% | 0.85% | 6.1分 |
| 16 | 微电生理 | 5.12% | -1.67% | 5.1分 |
| 18 | - | 3.90% | -5.52% | 分 |
| 20 | 大博医疗 | 3.33% | 1.71% | 5.9分 |
| 22 | 鱼跃医疗 | 2.94% | 0.30% | 6.4分 |
| 24 | 仁度生物 | 2.62% | 9.73% | 5.2分 |
| 26 | 麦克奥迪 | 2.45% | 0.71% | 5.1分 |
| 28 | 威高血净 | 2.45% | -0.36% | 5.2分 |
| 30 | - | 2.02% | -0.87% | 分 |
| 32 | 拱东医疗 | 1.49% | 3.92% | 5.7分 |
| 34 | 康德莱 | 1.04% | 2.94% | 5.8分 |
| 36 | 维力医疗 | 0.66% | 3.15% | 5.5分 |
| 38 | 迈克生物 | 0.52% | 2.03% | 5.2分 |
| 40 | 九强生物 | 0.23% | 0.45% | 4.5分 |
| 42 | 爱迪特 | 0.09% | 2.58% | 5.5分 |
| 44 | 健帆生物 | -0.70% | 1.07% | 5.1分 |
| 46 | 国发股份 | -0.96% | -0.32% | 5.0分 |
| 48 | 山东药玻 | -1.17% | -0.39% | 5.2分 |
| 50 | 安旭生物 | -1.48% | 0.52% | 4.7分 |
| 52 | 万东医疗 | -1.55% | -0.81% | 4.9分 |
| 54 | 天臣医疗 | -1.77% | -5.64% | 4.4分 |
| 56 | 奥美医疗 | -2.01% | -0.71% | 4.8分 |
| 58 | 安图生物 | -2.28% | 0.14% | 5.7分 |
| 60 | 新华医疗 | -2.47% | 0.76% | 4.8分 |
| 62 | 济民健康 | -2.54% | 3.56% | 5.1分 |
| 64 | 爱威科技 | -2.57% | 3.62% | 5.9分 |
| 66 | 西山科技 | -2.60% | 2.01% | 4.9分 |
| 68 | 健尔康 | -2.77% | 0.26% | 4.4分 |
| 70 | 蓝帆医疗 | -3.03% | -1.98% | 4.9分 |
| 72 | 东星医疗 | -3.13% | 1.48% | 4.8分 |
| 74 | 戴维医疗 | -3.15% | 2.79% | 5.3分 |
| 76 | 透景生命 | -3.49% | 2.90% | 4.8分 |
| 78 | 欧普康视 | -3.77% | 1.55% | 4.8分 |
| 80 | 迪瑞医疗 | -3.88% | 0.31% | 4.3分 |
| 82 | 普门科技 | -4.07% | 0.23% | 4.8分 |
| 84 | 联影医疗 | -4.21% | -0.87% | 5.6分 |
| 86 | 尚荣医疗 | -4.42% | 2.79% | 4.7分 |
| 88 | 山外山 | -4.50% | -0.75% | 5.1分 |
| 90 | 南卫股份 | -4.65% | 4.26% | 4.7分 |
| 92 | 祥生医疗 | -4.85% | 0.60% | 5.3分 |
| 94 | 澳华内镜 | -5.18% | -4.78% | 4.4分 |
| 96 | 天益医疗 | -5.36% | -0.24% | 5.2分 |
| 98 | 港通医疗 | -5.41% | 3.57% | 4.8分 |
| 100 | 圣湘生物 | -5.58% | 2.46% | 5.0分 |
| 102 | 易瑞生物 | -5.82% | 1.92% | 4.9分 |
| 104 | 海泰新光 | -5.83% | 0.73% | 4.7分 |
| 106 | 明德生物 | -5.87% | 0.68% | 4.0分 |
| 108 | 海利生物 | -6.27% | 1.62% | 4.2分 |
| 110 | 阳普医疗 | -6.65% | 2.90% | 5.1分 |
| 112 | 凯普生物 | -6.77% | 1.29% | 4.6分 |
| 114 | 英诺特 | -7.10% | -1.43% | 4.2分 |
| 116 | 天智航 | -7.48% | 2.17% | 5.0分 |
| 118 | 正川股份 | -7.56% | 2.13% | 4.7分 |
| 120 | 东方海洋 | -7.75% | 0.00% | 4.5分 |
| 122 | 康泰医学 | -7.85% | 0.13% | 4.4分 |
| 124 | 达安基因 | -8.45% | 0.00% | 4.6分 |
| 126 | 利德曼 | -9.50% | 2.03% | 4.4分 |
| 128 | 昊海生科 | -10.08% | -0.58% | 4.6分 |
| 130 | 中红医疗 | -11.58% | -0.92% | 4.6分 |
| 132 | 康为世纪 | -12.16% | 0.00% | 4.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 72/246 ， 72/246。
[{"date":"2025-09-30","value":"2.59","vol":"2.92"},{"date":"2025-06-30","value":"1.60","vol":"2.31"},{"date":"2025-03-31","value":"0.80","vol":"1.15"},{"date":"2024-12-31","value":"-3.78","vol":"0.62"},{"date":"2024-09-30","value":"1.96","vol":"4.68"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.59 | 1.60 | 0.80 | -3.78 | 1.96 |
| 行业(%) | 2.92 | 2.31 | 1.15 | 0.62 | 4.68 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"51.89","vol":"51.59"},{"date":"2025-06-30","value":"50.59","vol":"51.90"},{"date":"2025-03-31","value":"50.17","vol":"51.81"},{"date":"2024-12-31","value":"50.62","vol":"52.42"},{"date":"2024-09-30","value":"49.05","vol":"53.28"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
51.89 | 50.59 | 50.17 | 50.62 | 49.05 |
| 行业(%) | 51.59 | 51.90 | 51.81 | 52.42 | 53.28 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 42/246 ， 30/246。
[{"date":"2025-09-30","value":"5.03","vol":"-0.31"},{"date":"2025-06-30","value":"14.75","vol":"-1.69"},{"date":"2025-03-31","value":"7.56","vol":"-0.92"},{"date":"2024-12-31","value":"2.96","vol":"0.59"},{"date":"2024-09-30","value":"1.86","vol":"0.78"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
5.03 | 14.75 | 7.56 | 2.96 | 1.86 |
| 行业(%) | -0.31 | -1.69 | -0.92 | 0.59 | 0.78 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"27.09","vol":"-18.24"},{"date":"2025-06-30","value":"44.88","vol":"-20.12"},{"date":"2025-03-31","value":"100.03","vol":"-4.25"},{"date":"2024-12-31","value":"-193.80","vol":"-23.81"},{"date":"2024-09-30","value":"-56.59","vol":"-20.08"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
27.09 | 44.88 | 100.03 | -193.80 | -56.59 |
| 行业(%) | -18.24 | -20.12 | -4.25 | -23.81 | -20.08 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 64/246 ， 85/246。
[{"date":"2025-09-30","value":"0.23","vol":"0.25"},{"date":"2025-06-30","value":"0.16","vol":"0.17"},{"date":"2025-03-31","value":"0.08","vol":"0.08"},{"date":"2024-12-31","value":"0.29","vol":"0.36"},{"date":"2024-09-30","value":"0.22","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.23 | 0.16 | 0.08 | 0.29 | 0.22 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.05","vol":"1.67"},{"date":"2025-06-30","value":"0.74","vol":"1.12"},{"date":"2025-03-31","value":"0.35","vol":"0.55"},{"date":"2024-12-31","value":"1.30","vol":"2.32"},{"date":"2024-09-30","value":"1.03","vol":"1.65"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.05 | 0.74 | 0.35 | 1.30 | 1.03 |
| 行业(次) | 1.67 | 1.12 | 0.55 | 2.32 | 1.65 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"28.87","vol":"14.56"},{"date":"2025-06-30","value":"13.02","vol":"15.06"},{"date":"2025-03-31","value":"3.21","vol":"4.01"},{"date":"2024-12-31","value":"28.59","vol":"29.50"},{"date":"2024-09-30","value":"21.23","vol":"15.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 28.87 | 13.02 | 3.21 | 28.59 | 21.23 |
| 行业 | 14.56 | 15.06 | 4.01 | 29.50 | 15.40 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.02","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.00","vol":"2.18"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.02 | - | 1.00 | - |
| 行业 | 0.00 | 1.57 | 0.00 | 2.18 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 69/246 ， 73/246。
[{"date":"2025-09-30","value":"4.57","vol":"5.66"},{"date":"2025-06-30","value":"4.61","vol":"5.47"},{"date":"2025-03-31","value":"4.64","vol":"5.89"},{"date":"2024-12-31","value":"4.25","vol":"5.32"},{"date":"2024-09-30","value":"4.77","vol":"5.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.57 | 4.61 | 4.64 | 4.25 | 4.77 |
| 行业 | 5.66 | 5.47 | 5.89 | 5.32 | 5.88 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.62","vol":"4.53"},{"date":"2025-06-30","value":"3.62","vol":"4.37"},{"date":"2025-03-31","value":"3.57","vol":"4.77"},{"date":"2024-12-31","value":"3.28","vol":"4.30"},{"date":"2024-09-30","value":"3.62","vol":"4.74"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.62 | 3.62 | 3.57 | 3.28 | 3.62 |
| 行业 | 4.53 | 4.37 | 4.77 | 4.30 | 4.74 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 81/246 ， 80/246。
[{"date":"2025-09-30","value":"14.69","vol":"22.09"},{"date":"2025-06-30","value":"14.60","vol":"22.06"},{"date":"2025-03-31","value":"14.54","vol":"21.24"},{"date":"2024-12-31","value":"15.88","vol":"21.98"},{"date":"2024-09-30","value":"13.00","vol":"20.76"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
14.69 | 14.60 | 14.54 | 15.88 | 13.00 |
| 行业(%) | 22.09 | 22.06 | 21.24 | 21.98 | 20.76 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.18","vol":"0.72"},{"date":"2025-06-30","value":"0.18","vol":"0.58"},{"date":"2025-03-31","value":"0.18","vol":"0.57"},{"date":"2024-12-31","value":"0.20","vol":"0.55"},{"date":"2024-09-30","value":"0.15","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.18 | 0.18 | 0.18 | 0.20 | 0.15 |
| 行业(%) | 0.72 | 0.58 | 0.57 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"1.62","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-0.21","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.13","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-1.06","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]